Literature DB >> 23884232

An abnormal elevation of serum CA72-4 by ganoderma lucidum spore powder.

Yan Liang1, Mingjun He, Xiaoxia Fan, Weimin Ye, Zaixing Yang, Renqian Zhong.   

Abstract

We reported three patients with an abnormal elevation of serum CA72-4 levels when taking GLSP, which is commonly used as a dietary supplement for cancer patients across the globe. Furthermore, the results were not due to the apparent analytical interference. In case 1 and case 2, excessive examinations were carried out because of a lack of timely communication with patients when the abnormal elevation of CA724 was found. In contrast, the lesson from these two cases made us communicate with the patient in a timely manner in Case 3, avoiding unnecessary examinations when the same situation happened. Therefore, it is necessary to communicate with patients in a timely manner once an abnormal elevation of serum CA72-4 is found.

Entities:  

Keywords:  CA724; ganoderma lucidum; interference

Mesh:

Substances:

Year:  2013        PMID: 23884232

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  3 in total

1.  Dynamic biomarkers indicate the immunological benefits provided by Ganoderma spore powder in post-operative breast and lung cancer patients.

Authors:  Y Deng; J Ma; D Tang; Q Zhang
Journal:  Clin Transl Oncol       Date:  2021-01-06       Impact factor: 3.405

2.  A retrospective study of Ganoderma Lucidum Spore Powder for patients with epilepsy.

Authors:  Guo-Hui Wang; Xin Li; Wen-Hui Cao; Jing Li; Li-Hua Wang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

3.  The prognostic value of preoperative serum CA724 for CEA-normal colorectal cancer patients.

Authors:  Jiaan Kuang; Yizhen Gong; Hailun Xie; Ling Yan; Shizhen Huang; Feng Gao; Shuangyi Tang; Jialiang Gan
Journal:  PeerJ       Date:  2020-04-14       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.